Labiotech.eu

News and Trends 27 Jul 2016

New Vaccine could solve the problem of the costly Gilead’s Hepatitis C ‘Cure’

Artes Biotechnology and Burnet Institute will join their proprietary technologies to develop a novel vaccine for the Hepatitis C virus. This could create a more affordable solution to reduce the high HCV-related mortality. Hepatitis C remains a health problem around the world. WHO estimates that more than half a million people die every year from […]

July 27, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 26 Jul 2016

Be part of the European BioEconomy! Here are 3 Dutch GreenTech Events this Year

Here are 3 events to kickstart your greentech career. As Europe works towards a bioeconomy, challenges like these offer the opportunity to get involved and make Green ideas come to life. Put together by the students from Wageningen University, here are several bioeconomy and sustainability challenges for you to solve before the end of 2016. Maybe this could be a […]

July 26, 2016 - 4 minutesmins - By Dani Bancroft

News and Trends 26 Jul 2016

What is Lithuania’s role in European Biotech?

Since the days of the Soviet Union, Lithuania has always been considered as a leader in life sciences discoveries in Eastern Europe due to its infrastructure. But what about for Biotech? Nowadays, as a member of the NATO, the European Union, and Eurozone, Lithuania’s life science sector is growing around 20-25% annually; with special focus on […]

July 26, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 26 Jul 2016

This Malaria drug is being re-purposed for Cancer Radiotherapy

Cancer Research UK says an old anti-malaria drug could be repurposed as a cancer therapy. In pre-clinical studies, this drug increases oxygen levels in tumors, making them easier to treat with radiotherapy. Atovaquone has been on the market since 2000 as part of an anti-malarial drug. It is also commercialized by GSK under the name Mepron for […]

July 26, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 25 Jul 2016

Eczema could also be caused by Superbugs, so how could this Biotech fight it?

A new study has shown that on average, 70% of eczema patients are colonised with Staphylococcus aureus bacteria on their skin lesions (which include MRSA). Could this the Dutch biotech Micreos therefore have the solution to preventing spread of antibiotic-resistant strains in Eczema patients? Atopic dermatitis (eczema) is an extremely common skin affliction which can cause in painful lesions, […]

July 25, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 25 Jul 2016

Merck and Sigma-Aldrich: Together to solve the toughest problems in life science

In late 2015, the life science business of Merck joined forces with Sigma-Aldrich, bringing together two major life science players and completing the largest acquisition in the history of Merck KGaA, a leading science and technology company based in Darmstadt, Germany. We met with Klaus-Reinhard Bischoff, Head of Global Research & Applied Solutions Commercial Area […]

July 25, 2016 - 3 minutesmins - By Joachim Eeckhout

News and Trends 22 Jul 2016

German Biotech raises extra €31M to get first-in-class Antibody through trials

InflaRx, a German-based biopharma, has raised €31M in a series C fundraising. This is to further advance a potentially first-in-class antibody which targets an acute form of self-inflammation. Based in Jena, InflaRx’s founders originally identified C5a (a protein mostly produced in the liver) as a key ‘amplifying factor’ in complement inflammation. This then formed the basis for InflaRx’s candidate IFX-1 – […]

July 22, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 22 Jul 2016

Oryzon develops Epigenetic Therapies against Cancer and Alzheimer’s

This week we’re exchanging a very warm and welcoming country for another. We are heading to Barcelona, the wonderful capital of Catalunya in Spain, to visit Oryzon, our Biotech of The Week and maybe (just maybe) have a little swim in the Barceloneta beach. City: Barcelona (Spain) Founded: 2000 Employees: 35 Financial Data: €81.50M Market Cap (Bolsa de […]

July 22, 2016 - 2 minutesmins - By Joachim Eeckhout

More News! 22 Jul 2016

This startup is producing Synthetic Milk that tastes like your usual Breakfast Dairy

Muufri wants to launch cow-less milk onto the market by producing its essential components using bioengineered yeast. Since 75% of the world population is lactose intolerant, is it so surprising they have already secured over $2 million from investors? Co-founders Ryan Pandya (CEO) and Perumal Gandhi started working on making milk from scratch in April […]

July 22, 2016 - 4 minutesmins - By Clara Rodríguez Fernández

News and Trends 21 Jul 2016

‘Winner Antibody’ holds promise as universal Influenza A Vaccine

MedImmune and Humabs have reasons to be happy. Their candidate for an Influenza A vaccine has made it into well-known journal, Cell, boasting a unique affinity to the virus with multiple mechanisms to stop infection. The promising candidate is MEDI8852, an antibody initially developed by Humabs (Switzerland). It targets Influenza A virus (the group of viruses known as avian flu), […]

July 21, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 21 Jul 2016

Biotech-funded ‘Angels Initiative’ wants to create 1500 Stroke centres across Europe

Boehringer Ingelheim is funding a new initiative to tackle stroke in Europe, a leading cause of disability and death. Together with the European Stroke Organisation, it aims to have 1500 new stroke-ready centres by 2019. Cardiovascular diseases are now the #1 cause of death all over the world, killing an estimated 17.5 million people according to the […]

July 21, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 21 Jul 2016

UPDATED: French Gene Therapy for Blindness Launches another IPO

Update (21/07/2016): Gensight has successfully completed its IPO, raising €40M. This brings the Biotech’s total market capitalization to near €149M. The option of round oversubscription to €46M is still open. Originally published on 5/7/2016 After canceling its NASDAQ IPO back in April, GenSight is now launching on the Euronext Paris. It wants to raise €40M in total, […]

July 21, 2016 - 2 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

New Vaccine could solve the problem of the costly Gilead’s Hepatitis C ‘Cure’

Be part of the European BioEconomy! Here are 3 Dutch GreenTech Events this Year

What is Lithuania’s role in European Biotech?

This Malaria drug is being re-purposed for Cancer Radiotherapy

Eczema could also be caused by Superbugs, so how could this Biotech fight it?

Merck and Sigma-Aldrich: Together to solve the toughest problems in life science

German Biotech raises extra €31M to get first-in-class Antibody through trials

Oryzon develops Epigenetic Therapies against Cancer and Alzheimer’s

This startup is producing Synthetic Milk that tastes like your usual Breakfast Dairy

‘Winner Antibody’ holds promise as universal Influenza A Vaccine

Biotech-funded ‘Angels Initiative’ wants to create 1500 Stroke centres across Europe

UPDATED: French Gene Therapy for Blindness Launches another IPO

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!